Q2 2018 Holdings
Filed 2018-08-14 | 10 holdings | $8.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $8.3M | 700,000 | 96.8% |
| Aerie Pharmaceuticals, Inc.(AERIEUR) | COM | 00771V108 | $98.9K | 1,464,749 | 1.2% |
| Aimmune Therapeutics, Inc.(AIMT) | COM | 00900T107 | $90.3K | 3,356,749 | 1.1% |
| Alder BioPharmaceuticals, Inc.(ALDR1EUR) | COM | 014339105 | $26.6K | 1,686,220 | 0.3% |
| Insmed Incorporated(INSM) | COM | 457669307 | $22.9K | 967,636 | 0.3% |
| Epizyme, Inc.(EPZMEUR) | COM | 29428V104 | $19.9K | 1,468,215 | 0.2% |
| Acceleron Pharma Inc.(XLRN) | COM | 00434H108 | $11.9K | 244,756 | 0.1% |
| Denali Therapeutics Inc.(DNLI) | COM | 24823R105 | $3.8K | 250,000 | 0.0% |
| Sangamo Therapeutics, Inc.(SGMO) | COM | 800677106 | $1.1K | 80,500 | 0.0% |
| BioDelivery Sciences International, Inc.(BDSIUSD) | COM | 09060J106 | $90 | 30,500 | 0.0% |